vimarsana.com

Page 7 - அல்கெம் ஆய்வகங்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vitiligo Disease Market Report- Pfizer Inc, Centre Hospitalier Universitaire de Nice, Clinuvel Pharmaceuticals Ltd – KSU

Vitiligo Disease Market Report- Pfizer Inc, Centre Hospitalier Universitaire de Nice, Clinuvel Pharmaceuticals Ltd – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.

Quick Wrap: Nifty Pharma Index gains 3 04%

Nifty Pharma index closed up 3.04% at 12995.35 today. The index has gained 6.00% over last one month. Among the constituents, Cadila Healthcare Ltd added 9.29%, Cipla Ltd gained 4.88% and Alkem Laboratories Ltd jumped 4.65%. The Nifty Pharma index has soared 48.00% over last one year compared to the 62.81% increase in benchmark Nifty 50 index. In other indices, Nifty PSU Bank index gained 2.09% and Nifty Energy index is down 1.09% on the day. In broad markets, the Nifty 50 is down 0.26% to close at 14834.85 while the SENSEX has dropped 0.31% to close at 49591.32 today. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Pharmeasy parent enters unicorn club at $1 5 billion valuation

Pharmeasy parent enters unicorn club at $1.5 billion valuation SECTIONS Share Synopsis Pharmeasy’s $350 million funding round comes at a time when Reliance, Tata Group and Amazon are looking to tap the online pharmacy business by way of acquisitions. ETtech Pharmaeasy is the seventh startup unicorn this year, after Cred, Meesho, Digit Insurance, Innovaccer, Infra.Market and Five Star Finance. (Illustration: Rahul Awasthi/ETtech) Bengaluru: Prosus Ventures and US-based private equity firm TPG Capital are leading an investment of $350 million (about Rs 2,570 crore) in API Holdings, the parent company of Mumbai-based online pharmacy Pharmeasy. Prosus Ventures (previously Naspers Ventures) is the venture investing arm of South African technology and media conglomerate Prosus, which is one of the largest investors in Indian technology startups including Swiggy, Byju s and Meesho.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.